Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
New attack waves from the 'PhantomRaven' supply-chain campaign are hitting the npm registry, with dozens of malicious packages that exfiltrate sensitive data from JavaScript developers.
AI-powered bot hackerbot-claw exploited GitHub Actions workflows across Microsoft, DataDog, and CNCF projects over 7 days using 5 attack techniques. Bot achieved RCE in 5 of 7 targets, stole GitHub ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results